Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 73.76
-0.73 (-0.98%)
May 13, 2025, 3:00 PM CST
Xiamen Amoytop Biotech Market Cap
Xiamen Amoytop Biotech has a market cap or net worth of 30.01 billion as of May 13, 2025. Its market cap has increased by 18.34% in one year.
Market Cap
30.01B
Enterprise Value
29.21B
Revenue
2.95B
Ranking
n/a
PE Ratio
34.18
Stock Price
73.76
Market Cap Chart
Since January 17, 2020, Xiamen Amoytop Biotech's market cap has increased from 14.36B to 30.01B, an increase of 108.95%. That is a compound annual growth rate of 14.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 30.30B | 1.53% |
| Dec 31, 2024 | 29.85B | 40.15% |
| Dec 29, 2023 | 21.30B | 34.47% |
| Dec 30, 2022 | 15.84B | 32.96% |
| Dec 31, 2021 | 11.91B | -14.13% |
| Dec 31, 2020 | 13.87B | -3.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 335.80B |
| Shenzhen Mindray Bio-Medical Electronics | 270.90B |
| WuXi AppTec | 168.36B |
| Zhangzhou Pientzehuang Pharmaceutical., | 125.22B |
| Aier Eye Hospital Group | 119.56B |
| Sichuan Biokin Pharmaceutical | 112.28B |
| Shanghai United Imaging Healthcare | 112.08B |
| Yunnan Baiyao Group Co.,Ltd | 101.81B |